rs749443875
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_002234.4(KCNA5):c.852_869delCCCTCCGGCGCCCCACCA(p.His284_His289del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,862 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002234.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460862Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 726762
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Atrial fibrillation, familial, 7 Uncertain:1
This variant, c.852_869del, results in the deletion of 6 amino acid(s) of the KCNA5 protein (p.His284_His289del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KCNA5-related conditions. ClinVar contains an entry for this variant (Variation ID: 469600). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Testing was performed at Invitae. Seen at our center in a patient with ARVC. Given the weak gene-disease association, gene-phenotype mismatch, and lack of case data, we consider this variant a variant of uncertain significance and we do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). The KCNA5 gene is associated with autosomal dominant atrial fibrillation (MedGen UID: 393658). Additionally, the KCNA5 gene has preliminary evidence supporting a correlation with autosomal dominant pulmonary arterial hypertension (PAH) (PMID: 24936649). There is no established relationship with ARVC to date. The variant has not been reported in the literature (per PubMed and Google). Functional prediction algorithms are not available for this variant. The variant results in a 6 amino acid deletion but otherwise preserves integrity of the reading frame. The variant is not reported in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Latino, and Ashkenazi descent. However, given that this variant is a small indel, we can rely heavily on its absence since sequencing methods used in this cohort may not have detected this variant type. The average coverage at this site is 30x in genomes and 90x in exomes. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at